venBio

San Francisco, California

Firm Location:San Francisco, California • Burlingame, California • San Francisco Bay Area

Investor Firms That Co-Invest with venBio

RA Capital Mohr Davidow Ventures Foresite Capital Novo Ventures Atlas Venture Westlake Village BioPartners Venrock Vivo Capital Runway Growth Capital Nextech Invest Apollo Health Ventures Access Biotechnology Versant Ventures 5am Ventures OrbiMed Seroba Life Sciences

venBio Team

Photo of Robert Adelman, Managing Director at venBio

venBio·Managing Director

Sweet spot: $25.0M

Range: $20.0M - $30.0M

Investors in San Francisco (CA)

Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Robert

Photo of Richard Gaster, Managing Partner at venBio

venBio·Managing Partner

Sweet spot: $25.0M

Range: $20.0M - $30.0M

Investors in SF Bay Area (CA)

Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Richard

Photo of Corey Goodman, Managing Partner at venBio

venBio·Managing Partner

Sweet spot: $25.0M

Range: $20.0M - $30.0M

Investors in San Francisco (CA)

Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Corey

Photo of Jaume Pons, Venture Partner at venBio

venBio·Venture Partner

Sweet spot: $25.0M

Range: $20.0M - $30.0M

Investors in California

Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Jaume

Photo of Aaron Royston, Managing Partner at venBio

venBio·Managing Partner

Sweet spot: $25.0M

Range: $20.0M - $30.0M

Investors in SF Bay Area (CA)

Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed)

to see your intro paths to Aaron

Photo of Yvonne Yamanaka, Principal at venBio

Yvonne Yamanaka

venBio·Principal

Sweet spot: $25.0M

Range: $20.0M - $30.0M

Investors in SF Bay Area (CA)

Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists)

to see your intro paths to Yvonne